Ferran Nadeu/LinkedIn
Oct 22, 2025, 10:46
Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
Touch Medical Media shared on LinkedIn:
”A Conversation with Dr Ferran Nadeu – Touch Haematology Future Leaders 2025
As part of our Future Leaders 2025 series, we spoke with Dr Ferran Nadeu (Hospital Clínic de Barcelona, Spain) about his journey in cancer genomics and haematology.
In this interview, he reflects on the influence of mentorship, the excitement of translational discoveries, and how emerging genomic technologies are transforming our understanding of B-cell malignancies.
Read the full interview.”
More winner stories featured in Hemostasis Today.
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’